The biochemical activation mechanisms of SOXN involve a cascade of intracellular events triggered by various chemical activators. For instance, compounds that stimulate adenylyl cyclase result in a surge of cAMP levels, which in turn can augment SOXN transcriptional activity due to phosphorylation of CREB, a protein intimately involved in the regulation of gene expression. Similarly, when PKC is activated by certain molecules, it sets off a chain of downstream signaling that may culminate in the enhancement of SOXN activity, as PKC influences transcription factors that regulate gene expression, including those related to SOXN. Additionally, beta-adrenergic agonists work by increasing cAMP concentrations, thus potentially reinforcing SOXN activity via PKA signaling pathways, which are known to modulate the activity of key transcription factors.
Further contributing to the complexity of SOXN activation are compounds that affect intracellular calcium levels. Calcium ionophores, by increasing the cellular concentration of calcium ions, might indirectly stimulate SOXN through calcium-responsive signaling cascades, including calmodulin-dependent kinases, which are pivotal in regulating transcriptional processes. On another front, metabolic derivatives like retinoic acid have the capacity to regulate gene expression via their receptors, which could lead to enhanced SOXN activity by influencing transcriptional regulation. Additionally, the modulation of intracellular signaling by inhibiting certain kinases or by lithium-mediated inhibition of GSK-3, resulting in the activation of the Wnt signaling pathway, could also upregulate SOXN activity by affecting transcription factor function. Chromatin remodeling agents further enhance SOXN expression by increasing the accessibility of transcriptional machinery, while primary estrogens modulate gene expression and potentially promote SOXN activity through their receptors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can lead to downstream signaling pathways altering the activity of transcription factors that potentially increase SOXN activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts as a beta-adrenergic agonist elevating cAMP levels, thereby possibly enhancing SOXN activity through cAMP-dependent protein kinase A (PKA) signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases that increases cAMP and cGMP levels, potentially enhancing SOXN activity through PKA and PKG pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore raising intracellular calcium concentration, indirectly influencing SOXN activity through calcium-sensitive signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that can modulate intracellular calcium levels, affecting SOXN indirectly through calmodulin-dependent kinase pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that regulates gene expression through retinoic acid receptors, potentially enhancing SOXN activity by influencing its transcriptional regulation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that activates PKA, possibly leading to increased SOXN activity through phosphorylation of transcription factors. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), leading to the activation of Wnt signaling pathway, which may upregulate SOXN by influencing transcription factor activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that leads to chromatin remodeling, potentially enhancing SOXN expression by increasing accessibility of transcriptional machinery. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
A primary estrogen that through its receptor can modulate gene expression, potentially promoting SOXN activity by influencing transcriptional regulators. | ||||||